Custom Tirzepatide 15mg Manufacturing - High Quality Peptide for Medical Research

Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for diabetes research applications. This synthetic peptide demonstrates superior metabolic effects through simultaneous activation of both incretin receptors.

The 15mg formulation of tirzepatide offers researchers a stable, high-purity compound for investigating its unique mechanism of action. As a GIP receptor agonist, it enhances insulin secretion in a glucose-dependent manner while simultaneously activating GLP-1 receptors to promote satiety and weight management.

Our tirzepatide 15mg is manufactured under strict quality control standards, delivering consistent batch-to-batch reliability for research purposes. The lyophilized white powder maintains excellent stability when stored properly, ensuring research integrity throughout experimental timelines.

Key pharmacological characteristics of tirzepatide 15mg include its ability to improve glycemic control through multiple pathways while demonstrating favorable effects on body weight. These properties make it particularly valuable for metabolic disorder research programs.